Maternal-fetal transmission of Toxoplasma gondii in interferon-γ deficient pregnant mice

Parasitology International

Volumn 56, Issue 2, 2007, Pages 141-148

  Shiono, Yuko ^a   Mun, Hye Seong ^a   He, Na ^a   Nakazaki, Yuka ^a   Fang, Hao ^a   Furuya, Mitsuko ^a   Aosai, Fumie ^a   Yano, Akihiko ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Congenital toxoplasmosis; Interferon ; Intrauterine growth retardation; Toxoplasma gondii

Indexed keywords

GAMMA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BODY WEIGHT; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FETUS; GENE; GENETIC SUSCEPTIBILITY; INTRAUTERINE GROWTH RETARDATION; KNOCKOUT GENE; KNOCKOUT MOUSE; MALE; MOUSE; MOUSE STRAIN; NEWBORN; NONHUMAN; PARASITE IDENTIFICATION; PARASITE IMMUNITY; PARASITE TRANSMISSION; PLACENTAL TRANSFER; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SAG1 GENE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; DISEASE TRANSMISSION, VERTICAL; FEMALE; FETAL GROWTH RETARDATION; GENETIC PREDISPOSITION TO DISEASE; INTERFERON TYPE II; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PLACENTA; PLACENTA DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TOXOPLASMOSIS, CONGENITAL;

MUS; TOXOPLASMA GONDII;

EID: 33847608684     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2007.01.008     Document Type: Article

References (53)

1. Wong S.Y., and Remington J. Toxoplasmosis in pregnancy. Clin Infect Dis 18 (1994) 853-862
2. Montoya J.G., and Liesenfeld O. Toxoplasmosis. Lancet 363 (2004) 1965-1976
3. Remington J.S., Jacobs L., and Melton M.L. Congenital transmission of toxoplasmosis from mother animals with acute and chronic infections. J Infect Dis 108 (1961) 163-173
4. Hill D., and Dubey J.P. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect 8 (2002) 634-640
5. Cowen D., and Wolf A. Experimental congenital toxoplasmosis. III. Toxoplasmosis in the offspring of mice infected by the vaginal route. Incidence and manifestation of the disease. J Exp Med 92 (1950) 417-429
6. He N., Aosai F., Luo W.T., Ueda M., Yang T.H., Yamashita K., et al. Parasite load in pregnant mice infected by Toxoplasma gondii assayed by quantitiative competitive-PCR. Parasitol Int 46 (1997) 143-147
7. Hill J.A., Polgar K., and Anderson D.J. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 273 (1995) 1933-1936
8. Krishnan L., Guilbert L.J., Wegmann T.G., Belosevic M., and Mosmann T.R. T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions. Correlation with increased IFN-gamma and TNF and reduced IL-10 production by placental cells. J Immunol 156 (1996) 653-662
9. Marzi M., Viganò A., Trabattoni D., Villa M.L., Salvaggio A., Clerici E., et al. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 106 (1996) 127-133
10. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today 18 (1997) 478-482
11. Chaouat G., Zourbas S., Ostojic S., Lappree-Delage G., Dubanchet S., Ledee N., et al. A brief review of recent data on some cytokine expressions at the materno-foetal interface which might challenge the classical Th1/Th2 dichotomy. J Reprod Immunol 53 (2002) 241-256
12. Entrican G. Immune regulation during pregnancy and host-pathogen interactions in infectious abortion. J Comp Pathol 126 (2002) 79-94
13. Roberts C.W., Cruickshank S.M., and Alexander J. Sex-determined resistance to Toxoplasma gondii is associated with temporal differences in cytokine production. Infect Immun 63 (1995) 2549-2555
14. Vigano P., Gaffuri B., Somigliana E., Infantino M., Vignali M., and Di Blasio A.M. Interleukin-10 is produced by human uterine natural killer cells but does not affect their production of interferon-gamma. Mol Hum Reprod 7 (2001) 971-977
15. Loke Y.W. Transmission of parasites across the placenta. Adv Parasitol 21 (1982) 155-228
16. Mun H.S., Aosai F., Norose K., Chen M., Hata H., Tagawa Y., et al. Toxoplasma gondii Hsp70 as a danger signal in Toxoplasma gondii-infected mice. Cell Stress Chaperones 5 (2000) 328-335
17. Norose K., Mun H.S., Aosai F., Chen M., Hata H., Tagawa Y., et al. Organ infectivity of Toxoplasma gondii in interferon-γ knockout mice. J Parasitol 87 (2001) 447-452
18. Yano A., Mun H.S., Chen M., Norose K., Hata K., Kobayashi M., et al. Roles of IFN-γ on stage conversion of an obligate intracellular protozoan parasite, Toxoplasma gondii. Int Rev Immunol 21 (2002) 405-421
19. Belal U.S., Norose K., Aosai F., Mun H.S., Ahmed A.K., Chen M., et al. Evaluation of the effects of sulfamethoxazole on Toxoplasma gondii loads and stage conversion in IFN-γ knockout mice using QC-PCR. Microbiol Immunol 48 (2004) 185-193
20. Kudo M., Aosai F., Mun H.S., Norose K., Akira S., Iwakura Y., et al. The role of IFN-γ and Toll-like receptors in nephropathy induced by Toxoplasma gondii infection. Microbiol Immunol 48 (2004) 617-628
21. Piao L.X., Aosai F., Mun H.S., and Yano A. Peroral infectivity of Toxoplasma gondii in bile and feces of interferon-gamma knockout mice. Microbiol Immunol 49 (2005) 239-243
22. Howe D.K., and Sibley L.D. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis 172 (1995) 1561-1566
23. Aosai F., Mun H.S., Norose K., Chen M., Hata H., Kobayashi M., et al. Protective immunity induced by vaccination with SAG1 gene-transfected cells against Toxoplasma gondii-infection in mice. Microbiol Immunol 43 (1999) 87-91
24. Mun H.S., Aosai F., and Yano A. Role of Toxoplasma gondii HSP70 and Toxoplasma gondii HSP30/bag1 in antibody formation and prophylactic immunity in mice experimentally infected with Toxoplasma gondii. Microbiol Immunol 43 (1999) 471-479
25. Mun H.S., Aosai F., Norose K., Chen M., Piao L.X., Takeuchi O., et al. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection. Int Immunol 15 (2003) 1081-1087
26. Chen M., Aosai F., Norose K., Mun H.S., Ishikura H., Hirose S., et al. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice. Int Immunol 16 (2004) 937-946
27. Luo W., Aosai F., Ueda M., Yamashita K., Shimizu K., Sekiya S., et al. Kinetics in parasite abundance in susceptible and resistant mice infected with an avirulent strain of Toxoplasma gondii by using quantitative competitive PCR. J Parasitol 83 (1997) 1070-1074
28. Svetic A., Finkelman F.D., Jian Y.C., Dieffenbach C.W., Scott D.E., McCarthy K.F., et al. Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J Immunol 147 (1991) 2391-2397
29. Courret N., Darche S., Sonigo P., Milon G., Buzoni-Gatel D., and Tardieux I. CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 107 (2006) 309-316
30. Delgado M.A., and Santos-Buch C.A. Transplacental transmission and fetal parasitosis of Trypanosoma cruzi in outbred white Swiss mice. Am J Trop Med Hyg 27 (1978) 1108-1115
31. Jones T.C., Len L., and Hirsch J.G. Assessment in vitro of immunity against Toxoplasma gondii. J Exp Med 141 (1975) 466-482
32. Letscher-Bru V., Pfaff A.W., Abou-Bacar A., Filisetti D., Antoni E., Villard O., et al. Vaccination with Toxoplasma gondii SAG-1 protein is protective against congenital toxoplasmosis in BALB/c mice but not in CBA/J mice. Infect Immun 71 (2003) 6615
33. Hedvall E. Pregnancy and tuberculosis. Acta Med Scand Suppl 286 (1953) l-101
34. Diro M., and Beydoun S.N. Malaria in pregnancy. South Med J 75 (1982) 959-962
35. Boyd JD, Hamilton WJ, The Human Placenta (Heffer and Sons, eds.). Cambridge. 1970.
36. Roberts C.W., Brewer J.M., and Alexander J. Congenital toxoplasmosis in the Balb/c mouse: prevention of vertical disease transmission and fetal death by vaccination. Vaccine 12 (1994) 1389
37. Abou-Bacar A., Pfaff A.W., Georges S., Letscher-Bru V., Filisetti D., Villard O., et al. Role of NK cells and gamma interferon in transplacental passage of Toxoplasma gondii in a mouse model of primary infection. Infect Immun 72 (2004) 1397
38. Norose K., Aosai F., Mizota A., Yamamoto S., Mun H.S., and Yano A. Deterioration of visual function as examined by electroretinograms in Toxoplasma gondii-infected IFN-gamma-knockout mice. Invest Ophthalmol Vis Sci 46 (2005) 317-321
39. Chen H.L., Kamath R., Pace J.L., Russell S.W., and Hunt J.S. Expression of the interferon-gamma receptor gene in mouse placentas is related to stage of gestation and is restricted to specific subpopulations of trophoblast cells. Placenta 15 (1994) 109-121
40. He N., Aosai F., Mun H.S., Sekiya S., and Yano A. Cytokine production assayed by RT-PCR in pregnant mice infected by Toxoplasma gondii as a model of congenital toxoplasmosis. Jpn J Trop Med Hyg 25 (1997) 59-67
41. Suzuki Y., Kang H., Parmley S., Lim S., and Park D. Induction of tumor necrosis factor-alpha and inducible nitric oxide synthase fails to prevent toxoplasmic encephalitis in the absence of interferon-gamma in genetically resistant BALB/c mice. Microbes Infect 2 (2000) 455-462
42. Munn D.H., Zhou M., Attwood J.T., Bondarev I., Conway S.J., Marshall B., et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281 (1998) 1191-1193
43. Xu C., Mao D., Holers V.M., Palanca B., Cheng A.M., and Molina H. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 287 (2000) 498-501
44. Margni R.A., and Malan B.I. Paradoxical behavior of asymmetric IgG antibodies. Immunol Rev 163 (1998) 77-87
45. Aluvihare V.R., Kallikourdis M., and Betz A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immun 5 (2004) 266-271
46. +T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol 166 (2005) 811-822
47. Fest S., Zenclussen A.C., Joachim R., Hagen E., Demuth H.U., and Hoffmann T. Stress and substance P but not the substance P-metabolite SP5-11 trigger murine abortion by augmenting TNF-alpha levels at the feto-maternal interface. Scand J Immunol 63 (2006) 42-49
48. Bang A.T., Baitule S.B., Reddy H.M., Deshmukh M.D., and Bang R.A. Low birth weight and preterm neonates: can they be managed at home by mother and a trained village health worker?. J Perinatol 25 (2005) S72-S81
49. Redline R.W., Heller D., Keating S., and Kingdom J. Placental diagnostic criteria and clinical correlation-a workshop report. Placenta 26 (2005) S114-S117
50. Steketee R.W., Nahlen B.L., Parise M.E., and Menéndez C. The burden of malaria in pregnancy in malaria endemic areas. Am J Trop Med Hyg 64 (2001) 28-35
51. Brabin B.J., Romagosa C., Abdelgalil S., Menendez C., Verhoeff F.H., McGready R., et al. The sick placenta-the role of malaria. Placenta 25 (2004) 359-378
52. Remington J.S., Klein J.O., Wilson C.B., and Baker C.J. Infectious diseases of the fetus and newborn infant (2006), Elsevier, Philadelphia
53. Yano A., Kubota N., Kasai T., Nakayashiro M., Norose K., Hata H., et al. Congenital Toxoplasma infection at placenta resulting in intrauterine growth retardation. Jpn J Trop Med Hyg 29 (2001) 52